Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SGEN | Common Stock | Options Exercise | $17.1K | +850 | +1.84% | $20.06* | 47.1K | Jan 28, 2022 | Direct | F1 |
transaction | SGEN | Common Stock | Sale | -$103K | -850 | -1.8% | $121.69 | 46.3K | Jan 28, 2022 | Direct | F1, F2, F3 |
transaction | SGEN | Common Stock | Options Exercise | $51.2K | +2.55K | +5.52% | $20.06* | 48.8K | Jan 28, 2022 | Direct | F1 |
transaction | SGEN | Common Stock | Sale | -$313K | -2.55K | -5.23% | $122.43 | 46.3K | Jan 28, 2022 | Direct | F1, F2, F4 |
transaction | SGEN | Common Stock | Options Exercise | $17.7K | +883 | +1.91% | $20.06* | 47.1K | Jan 28, 2022 | Direct | F1 |
transaction | SGEN | Common Stock | Sale | -$109K | -883 | -1.87% | $123.39 | 46.3K | Jan 28, 2022 | Direct | F1, F2, F5 |
transaction | SGEN | Common Stock | Options Exercise | $4.29K | +214 | +0.46% | $20.06* | 46.5K | Jan 28, 2022 | Direct | F1 |
transaction | SGEN | Common Stock | Sale | -$26.6K | -214 | -0.46% | $124.23 | 46.3K | Jan 28, 2022 | Direct | F1, F2, F6 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -850 | -6.54% | $0.00 | 12.2K | Jan 28, 2022 | Common Stock | 850 | $20.06 | Direct | F7 |
transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -2.55K | -21.01% | $0.00 | 9.6K | Jan 28, 2022 | Common Stock | 2.55K | $20.06 | Direct | F7 |
transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -883 | -9.2% | $0.00 | 8.71K | Jan 28, 2022 | Common Stock | 883 | $20.06 | Direct | F7 |
transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -214 | -2.46% | $0.00 | 8.5K | Jan 28, 2022 | Common Stock | 214 | $20.06 | Direct | F7 |
Id | Content |
---|---|
F1 | Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. |
F2 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. |
F3 | Reflects sales of common stock executed in multiple transactions at prices ranging from $120.99 to $121.96. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
F4 | Reflects sales of common stock executed in multiple transactions at prices ranging from $122.03 to $122.97. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
F5 | Reflects sales of common stock executed in multiple transactions at prices ranging from $123.04 to $124.03. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
F6 | Reflects sales of common stock executed in multiple transactions at prices ranging from $124.13 to $124.29. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
F7 | Options were fully vested on 5/17/13. |